Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Tomohiro Yoshida(Mitsubishi Tanabe Pharma Corporation), Fumihiko Akahoshi(Mitsubishi Tanabe Pharma Corporation), Hiroshi Sakashita(Mitsubishi Tanabe Pharma Corporation), Hiroshi Kitajima(Mitsubishi Tanabe Pharma Corporation), Mitsuharu Nakamura(Mitsubishi Tanabe Pharma Corporation), Shuji Sonda(Mitsubishi Tanabe Pharma Corporation), Masahiro Takeuchi(Mitsubishi Tanabe Pharma Corporation), Yoshihito Tanaka(Mitsubishi Tanabe Pharma Corporation), Naoko Ueda(Mitsubishi Tanabe Pharma Corporation), Sumie Sekiguchi(Mitsubishi Tanabe Pharma Corporation), Takayuki Ishige(Mitsubishi Tanabe Pharma Corporation), Kyoko Shima(Mitsubishi Tanabe Pharma Corporation), Mika Nabeno(Mitsubishi Tanabe Pharma Corporation), Yuji Abe(Mitsubishi Tanabe Pharma Corporation), Jun Anabuki(Mitsubishi Tanabe Pharma Corporation), Aki Soejima(Mitsubishi Tanabe Pharma Corporation), Kumiko Yoshida(Mitsubishi Tanabe Pharma Corporation), Yoko Takashina(Mitsubishi Tanabe Pharma Corporation), Shin‐ichi Ishii(Mitsubishi Tanabe Pharma Corporation), Satoko Kiuchi(Mitsubishi Tanabe Pharma Corporation), Sayaka Fukuda(Mitsubishi Tanabe Pharma Corporation), Reiko Tsutsumiuchi(Mitsubishi Tanabe Pharma Corporation), Keigo Kosaka(Mitsubishi Tanabe Pharma Corporation), Takahiro Murozono(Mitsubishi Tanabe Pharma Corporation), Yoshinobu Nakamaru(Mitsubishi Tanabe Pharma Corporation), Hiroyuki Utsumi(Mitsubishi Tanabe Pharma Corporation), Naoya Masutomi(Mitsubishi Tanabe Pharma Corporation), Hiroyuki Kishida(Mitsubishi Chemical (Japan)), I. Miyaguchi(Mitsubishi Chemical (Japan)), Yoshiharu Hayashi(Mitsubishi Tanabe Pharma Corporation)
Cited by 150Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis